BIGHAM MICHAEL (Chairman and CEO) sold 1.3% of their position (15.75K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $31.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/22/2022ACC: 0000904454-22-000647
DirectorOfficer· Chairman and CEO
Since Jul 2018
+29.25K
Net shares
Net buyer
$31.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
45K acquired · 15.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+45K
Price / share
—
Trade value
—
% of position
3.8%
12/20/2022
1.18M→1.23M
Common Stock
Direct
Shares
−15.75K
Price / share
$1.99
Trade value
$31.34K
% of position
1.3%
12/21/2022
1.23M→1.21M
Total
Net shares
+29.25K
Net value
-$31.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/20/2022 | A · Award | +45K | — | — | 3.8% | 1.18M | 1.23M |
| Common Stock Direct | 12/21/2022 | S · Sale | −15.75K | $1.99 | $31.34K | 1.3% | 1.23M | 1.21M |
| Total | +29.25K | -$31.34K | ||||||
Derivative Transactions0
No derivative transactions reported